Anti-human CEACAM5 monoclonal antibody, labetuzumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1047-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: IMMU-130, hMN-14-SN-38, hMN-14-SN-38 ADC, hMN14-CL-SN-38, hMN14-SN-38
target CEACAM5
alias CEACAM-5, CD66e, CEA, Meconium antigen 100
gene id Uniprot ID: P06731
host species Humanized
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human CEACAM5, His tagged protein binds to Anti-CEACAM5 Neutralizing antibody in a linear range of 2.56-320 ng/ml.

Flow cytometry analysis with Anti-CEACAM5 (labetuzumab) on Expi293 cells transfected with human CEACAM5 (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).

Flow cytometry analysis of antigen binding of anti-human CEACAM5 mAb. (A) A clear peak shift of The antibody was seen compared to the control when incubated with CEACAM5-expressing MKN45 cells, indicating strong binding of The antibody to CEACAM5. Antibodies were incubated at 2 ug/mL.


PRODUCT

  • SKU

    DMS1047-100ug

  • Size

    100ug

  • Price

    $350

1